Abstract
Background According to the World Health Organization (WHO), approximately 322 million individuals globally were grappling with depressive disorders in 2015. During pregnancy, the risk of experiencing depression is elevated due to certain hormonal changes. Despite the potentially severe consequences of antenatal depression for both the mother and newborn, there have been limited studies conducted on this issue in Bangladesh.
Objective To find out the prevalence and associated factors of antenatal depression in a rural sub-district in Bangladesh.
Method A cross-sectional study was performed in Lohagara, a rural subdistrict in Narail, situated in the southern part of Bangladesh between January 08 and 14, 2024. 350 subjects were recruited for the study, who were pregnant at various trimesters and attended antenatal check-ups in a government health complex and a private hospital in Lohagara. The Bengali-translated version of the Edinburgh Postnatal Depression Scale (EPDS) and a structured questionnaire were used for data collection. Data were analyzed in STATA version 14.
Result The point prevalence of antenatal depression is 39% (38.86%, in 95% CI: 33.9% to 44%). Gestational week (AOR: 0.4, 95% CI: 0.2, 0.8), unintended pregnancy (AOR: 1.7, 95% CI: 1, 3), intimate partner violence (AOR: 3.3, 95% CI: 1.1, 9.7), a history of previous diseases (AOR: 2.4, 95% CI: 1.1, 5.2), and the history of having polygamous husbands (AOR: 13.6, 95% CI: 1.1, 164) are found to be significantly associated with the development of depression in the prenatal period.
Conclusion In rural Narail, high rates of antenatal depression underscore the importance of increased awareness among healthcare professionals and families. Strategic involvement of stakeholders and policymakers is essential to address issues like intimate partner violence and polygamy. Moreover, there’s a critical need for extra care and counseling for pregnant women with a history of health problems or facing unexpected pregnancies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by-Institutional Review Board/Ethics Review Committee (IRB/ERC), North South University Approval Number: 2023/OR-NSU/IRB/1224
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All raw data files are available in the figshare database (DOI Number: 10.6084/m9.figshare.24994110).
